

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 7.43562339 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.11896721 |
| 3 | T cell lineage commitment (GO:0002360) | 6.08593172 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.76732300 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.76732300 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 5.68120160 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 5.08177879 |
| 8 | regulation of regulatory T cell differentiation (GO:0045589) | 5.07986799 |
| 9 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.94821014 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.92410707 |
| 11 | negative T cell selection (GO:0043383) | 4.86210793 |
| 12 | tolerance induction (GO:0002507) | 4.79160250 |
| 13 | regulation of T cell tolerance induction (GO:0002664) | 4.77967558 |
| 14 | B cell homeostasis (GO:0001782) | 4.75615472 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.70741126 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68721802 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.60180206 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.46256762 |
| 19 | positive regulation of tolerance induction (GO:0002645) | 4.37221599 |
| 20 | definitive hemopoiesis (GO:0060216) | 4.30491571 |
| 21 | B cell proliferation (GO:0042100) | 4.28023383 |
| 22 | interferon-gamma production (GO:0032609) | 4.27104761 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.23757947 |
| 24 | mast cell activation (GO:0045576) | 4.17663731 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.13623625 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 4.13389862 |
| 27 | positive T cell selection (GO:0043368) | 4.11977290 |
| 28 | leukocyte aggregation (GO:0070486) | 4.10202310 |
| 29 | T cell migration (GO:0072678) | 4.05043197 |
| 30 | T cell selection (GO:0045058) | 4.03175446 |
| 31 | regulation of tolerance induction (GO:0002643) | 3.98064002 |
| 32 | T cell homeostasis (GO:0043029) | 3.94713558 |
| 33 | thymic T cell selection (GO:0045061) | 3.94108942 |
| 34 | viral transcription (GO:0019083) | 3.88983968 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.77581674 |
| 36 | translational termination (GO:0006415) | 3.71179428 |
| 37 | response to interleukin-15 (GO:0070672) | 3.67323438 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.67226045 |
| 39 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.65972796 |
| 40 | ribosomal small subunit biogenesis (GO:0042274) | 3.65378506 |
| 41 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.64943562 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.63933005 |
| 43 | negative regulation of B cell proliferation (GO:0030889) | 3.61790172 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58511302 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.58511302 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58511302 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58511302 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58511302 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.58511302 |
| 50 | alpha-beta T cell activation (GO:0046631) | 3.56517979 |
| 51 | T cell receptor signaling pathway (GO:0050852) | 3.55971701 |
| 52 | T cell differentiation (GO:0030217) | 3.55567104 |
| 53 | Peyers patch development (GO:0048541) | 3.54877333 |
| 54 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.54877333 |
| 55 | megakaryocyte development (GO:0035855) | 3.54267881 |
| 56 | regulation of B cell proliferation (GO:0030888) | 3.52645786 |
| 57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.52079606 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.47927977 |
| 59 | positive regulation of T cell cytokine production (GO:0002726) | 3.46474693 |
| 60 | alpha-beta T cell differentiation (GO:0046632) | 3.45770821 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45694145 |
| 62 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.43396706 |
| 63 | histone H3-K4 trimethylation (GO:0080182) | 3.41206539 |
| 64 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.40991945 |
| 65 | positive regulation of humoral immune response (GO:0002922) | 3.38188131 |
| 66 | cotranslational protein targeting to membrane (GO:0006613) | 3.37999763 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.35893306 |
| 68 | protein targeting to ER (GO:0045047) | 3.33156707 |
| 69 | myeloid dendritic cell activation (GO:0001773) | 3.32618224 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.28959285 |
| 71 | positive regulation of granulocyte differentiation (GO:0030854) | 3.28592005 |
| 72 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26723618 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.20858157 |
| 74 | lymphoid progenitor cell differentiation (GO:0002320) | 3.20791074 |
| 75 | myeloid dendritic cell differentiation (GO:0043011) | 3.20755182 |
| 76 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19205982 |
| 77 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18145784 |
| 78 | mature B cell differentiation (GO:0002335) | 3.16271048 |
| 79 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14990791 |
| 80 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.13761069 |
| 81 | protein localization to endoplasmic reticulum (GO:0070972) | 3.13747486 |
| 82 | regulation of interleukin-13 production (GO:0032656) | 3.13675968 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.12437524 |
| 84 | positive regulation of B cell proliferation (GO:0030890) | 3.12185316 |
| 85 | regulation of interleukin-4 production (GO:0032673) | 3.11177938 |
| 86 | positive regulation of interleukin-4 production (GO:0032753) | 3.09867349 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09772913 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 3.08626380 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.08626380 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07986271 |
| 91 | regulation of B cell differentiation (GO:0045577) | 3.07739197 |
| 92 | translational elongation (GO:0006414) | 3.06413144 |
| 93 | lymphocyte migration (GO:0072676) | 3.05743783 |
| 94 | germinal center formation (GO:0002467) | 3.05421537 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04054088 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.02165568 |
| 97 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.01971635 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 3.01387877 |
| 99 | regulation of isotype switching (GO:0045191) | 3.00748024 |
| 100 | mast cell activation involved in immune response (GO:0002279) | 3.00229010 |
| 101 | mast cell degranulation (GO:0043303) | 3.00229010 |
| 102 | regulation of alpha-beta T cell activation (GO:0046634) | 2.99794076 |
| 103 | T-helper cell differentiation (GO:0042093) | 2.98586556 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.98586556 |
| 105 | histone H3-K36 demethylation (GO:0070544) | 2.98287675 |
| 106 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.96669622 |
| 107 | negative regulation of cell killing (GO:0031342) | 2.95583755 |
| 108 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95583755 |
| 109 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94994259 |
| 110 | response to protozoan (GO:0001562) | 2.94044604 |
| 111 | T cell costimulation (GO:0031295) | 2.93981612 |
| 112 | lymphocyte homeostasis (GO:0002260) | 2.93929151 |
| 113 | regulation of protein heterodimerization activity (GO:0043497) | 2.93757242 |
| 114 | lymphocyte costimulation (GO:0031294) | 2.93019072 |
| 115 | regulation of B cell activation (GO:0050864) | 2.92547708 |
| 116 | natural killer cell differentiation (GO:0001779) | 2.90784044 |
| 117 | T cell activation (GO:0042110) | 2.89358976 |
| 118 | lymphocyte proliferation (GO:0046651) | 2.89083279 |
| 119 | positive regulation of developmental pigmentation (GO:0048087) | 2.89009590 |
| 120 | positive regulation of B cell activation (GO:0050871) | 2.88912617 |
| 121 | regulation of interleukin-2 production (GO:0032663) | 2.88159129 |
| 122 | defense response to protozoan (GO:0042832) | 2.87479096 |
| 123 | lymph node development (GO:0048535) | 2.87287019 |
| 124 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.87087736 |
| 125 | peptidyl-lysine methylation (GO:0018022) | 2.84825451 |
| 126 | fucose catabolic process (GO:0019317) | 2.84485395 |
| 127 | L-fucose metabolic process (GO:0042354) | 2.84485395 |
| 128 | L-fucose catabolic process (GO:0042355) | 2.84485395 |
| 129 | viral life cycle (GO:0019058) | 2.84411600 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83982176 |
| 131 | regulation of germinal center formation (GO:0002634) | 2.83432657 |
| 132 | mononuclear cell proliferation (GO:0032943) | 2.81956290 |
| 133 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.81784824 |
| 134 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.79164549 |
| 135 | cytidine deamination (GO:0009972) | 2.77705458 |
| 136 | cytidine metabolic process (GO:0046087) | 2.77705458 |
| 137 | cytidine catabolic process (GO:0006216) | 2.77705458 |
| 138 | cellular protein complex disassembly (GO:0043624) | 2.76715183 |
| 139 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76665425 |
| 140 | positive regulation of defense response to virus by host (GO:0002230) | 2.76473346 |
| 141 | detection of bacterium (GO:0016045) | 2.76028319 |
| 142 | lymphocyte differentiation (GO:0030098) | 2.75365191 |
| 143 | response to host immune response (GO:0052572) | 2.75316180 |
| 144 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75316180 |
| 145 | V(D)J recombination (GO:0033151) | 2.75254326 |
| 146 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.74964506 |
| 147 | leukocyte homeostasis (GO:0001776) | 2.74585839 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.74419749 |
| 149 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.69449027 |
| 150 | response to interferon-beta (GO:0035456) | 2.68829037 |
| 151 | response to type I interferon (GO:0034340) | 2.68699807 |
| 152 | negative regulation of adaptive immune response (GO:0002820) | 2.68410842 |
| 153 | type I interferon signaling pathway (GO:0060337) | 2.66171930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.19060667 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.83784780 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15303256 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.11537142 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.02033940 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.76182968 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.66930860 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45039149 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44217802 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34091796 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29617730 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.08513983 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.04639644 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97409466 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.92386791 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.91376682 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88943144 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.82964210 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75058138 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.66231599 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.52128383 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.50271063 |
| 23 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.42059096 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29762939 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24055268 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.23442239 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20254649 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20096667 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.15234302 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12890488 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08419388 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03487340 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99508448 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94873318 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.91754879 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91674233 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88553527 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84732562 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77644384 |
| 40 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.77114617 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76990619 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.76810455 |
| 43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71093848 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69897705 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68366486 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67243526 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64777012 |
| 48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64531934 |
| 49 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60480879 |
| 50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59046912 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58190747 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56067468 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54436863 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49508259 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.45831096 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44670341 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42082876 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.40720331 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39076093 |
| 60 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36794195 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35204934 |
| 62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32159457 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31063772 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.28890489 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28732600 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28418584 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24469384 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21727073 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16743047 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16244480 |
| 71 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15468077 |
| 72 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14128361 |
| 73 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11842438 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08840788 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04175566 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.03743292 |
| 77 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03733899 |
| 78 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02612882 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01187700 |
| 80 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01008126 |
| 81 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00469887 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99973941 |
| 83 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97800773 |
| 84 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.97056213 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95853679 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95738979 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92232931 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92090723 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89151853 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89065755 |
| 91 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.88306743 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86625503 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85920045 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85122644 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84661745 |
| 96 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84154309 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84094491 |
| 98 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82809496 |
| 99 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.82602846 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.82098380 |
| 101 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.81728682 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80164381 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79836470 |
| 104 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.78854009 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78730034 |
| 106 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.77484454 |
| 107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77108944 |
| 108 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.76287401 |
| 109 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.76032688 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75833865 |
| 111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75314425 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74555410 |
| 113 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.70583430 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69971875 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68519131 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67811857 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66401327 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66332059 |
| 119 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.66316257 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66215263 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66038979 |
| 122 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.65995658 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.65508307 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63778239 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.62340405 |
| 126 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.60056516 |
| 127 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.59681004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.80180323 |
| 2 | MP0005671_abnormal_response_to | 3.83283112 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.38234727 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.97523414 |
| 5 | MP0003724_increased_susceptibility_to | 2.85247150 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.77388382 |
| 7 | MP0000685_abnormal_immune_system | 2.75700307 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 2.60874474 |
| 9 | MP0001873_stomach_inflammation | 2.58357137 |
| 10 | MP0001800_abnormal_humoral_immune | 2.51189166 |
| 11 | MP0002398_abnormal_bone_marrow | 2.46929568 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.46585579 |
| 13 | MP0009785_altered_susceptibility_to | 2.45047130 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.44730912 |
| 15 | * MP0001819_abnormal_immune_cell | 2.43087828 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.40791725 |
| 17 | MP0002723_abnormal_immune_serum | 2.33601519 |
| 18 | MP0001790_abnormal_immune_system | 2.33416515 |
| 19 | MP0005387_immune_system_phenotype | 2.33416515 |
| 20 | MP0003866_abnormal_defecation | 2.26586811 |
| 21 | MP0002006_tumorigenesis | 2.26493510 |
| 22 | MP0004381_abnormal_hair_follicle | 2.25026724 |
| 23 | MP0003303_peritoneal_inflammation | 2.23751501 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.21027306 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.20626760 |
| 26 | MP0005025_abnormal_response_to | 2.19303781 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.18297866 |
| 28 | MP0000716_abnormal_immune_system | 2.13206562 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 2.08067726 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.05895547 |
| 31 | MP0002405_respiratory_system_inflammati | 2.02626701 |
| 32 | MP0002722_abnormal_immune_system | 1.99751697 |
| 33 | MP0002009_preneoplasia | 1.99359183 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.99238013 |
| 35 | MP0000490_abnormal_crypts_of | 1.93454676 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.86842414 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.82914497 |
| 38 | MP0003436_decreased_susceptibility_to | 1.82100422 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.81384927 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.81265705 |
| 41 | MP0002419_abnormal_innate_immunity | 1.81094790 |
| 42 | MP0003045_fibrosis | 1.80234448 |
| 43 | MP0002429_abnormal_blood_cell | 1.77917136 |
| 44 | MP0004947_skin_inflammation | 1.77331435 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.77239747 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.77239747 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.73059750 |
| 48 | MP0002163_abnormal_gland_morphology | 1.70557215 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.66789180 |
| 50 | MP0001853_heart_inflammation | 1.61140875 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.60302028 |
| 52 | MP0001188_hyperpigmentation | 1.57902428 |
| 53 | MP0005409_darkened_coat_color | 1.53163980 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.51443005 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.45470824 |
| 56 | MP0002132_abnormal_respiratory_system | 1.42405310 |
| 57 | MP0008057_abnormal_DNA_replication | 1.39284805 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.34891058 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.33893356 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.33696094 |
| 61 | MP0000383_abnormal_hair_follicle | 1.24928889 |
| 62 | MP0002933_joint_inflammation | 1.21466470 |
| 63 | MP0001851_eye_inflammation | 1.20931164 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.19929939 |
| 65 | MP0009379_abnormal_foot_pigmentation | 1.16739533 |
| 66 | MP0000858_altered_metastatic_potential | 1.16142851 |
| 67 | MP0010307_abnormal_tumor_latency | 1.15570068 |
| 68 | MP0008058_abnormal_DNA_repair | 1.10228461 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.08893699 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.06957837 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.06200976 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.05738291 |
| 73 | MP0006082_CNS_inflammation | 1.03744200 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.00569907 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.98698630 |
| 76 | MP0005310_abnormal_salivary_gland | 0.98513227 |
| 77 | MP0003091_abnormal_cell_migration | 0.97408118 |
| 78 | MP0003943_abnormal_hepatobiliary_system | 0.95680385 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.93497326 |
| 80 | MP0000371_diluted_coat_color | 0.92065931 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.91142205 |
| 82 | MP0000372_irregular_coat_pigmentation | 0.90944405 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.90463804 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.89536365 |
| 85 | MP0000350_abnormal_cell_proliferation | 0.89216439 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.86959415 |
| 87 | MP0002928_abnormal_bile_duct | 0.86589464 |
| 88 | MP0005451_abnormal_body_composition | 0.86238977 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.85872131 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.84707846 |
| 91 | MP0003077_abnormal_cell_cycle | 0.83257648 |
| 92 | MP0008469_abnormal_protein_level | 0.82944790 |
| 93 | MP0003786_premature_aging | 0.82908557 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.81604261 |
| 95 | MP0001191_abnormal_skin_condition | 0.81157353 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.75427240 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.75220693 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.73528045 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.71831207 |
| 100 | MP0009115_abnormal_fat_cell | 0.69404496 |
| 101 | MP0008877_abnormal_DNA_methylation | 0.67976080 |
| 102 | MP0003941_abnormal_skin_development | 0.67316752 |
| 103 | MP0009278_abnormal_bone_marrow | 0.66709958 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.65161308 |
| 105 | MP0000313_abnormal_cell_death | 0.64345111 |
| 106 | MP0005621_abnormal_cell_physiology | 0.63063486 |
| 107 | MP0003315_abnormal_perineum_morphology | 0.62009632 |
| 108 | MP0002796_impaired_skin_barrier | 0.61926054 |
| 109 | MP0009931_abnormal_skin_appearance | 0.60185434 |
| 110 | MP0002098_abnormal_vibrissa_morphology | 0.59661468 |
| 111 | MP0004145_abnormal_muscle_electrophysio | 0.59254462 |
| 112 | MP0002060_abnormal_skin_morphology | 0.58662202 |
| 113 | MP0003252_abnormal_bile_duct | 0.58467852 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.57835540 |
| 115 | MP0000377_abnormal_hair_follicle | 0.57784825 |
| 116 | MP0003828_pulmonary_edema | 0.57760987 |
| 117 | MP0003448_altered_tumor_morphology | 0.57374432 |
| 118 | MP0009763_increased_sensitivity_to | 0.57197845 |
| 119 | MP0003868_abnormal_feces_composition | 0.56922380 |
| 120 | MP0002168_other_aberrant_phenotype | 0.56378701 |
| 121 | MP0009764_decreased_sensitivity_to | 0.56344602 |
| 122 | MP0000367_abnormal_coat/_hair | 0.55443617 |
| 123 | MP0003567_abnormal_fetal_cardiomyocyte | 0.55183428 |
| 124 | MP0006054_spinal_hemorrhage | 0.54945601 |
| 125 | MP0010678_abnormal_skin_adnexa | 0.52763213 |
| 126 | MP0001663_abnormal_digestive_system | 0.51739757 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.51699836 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50825583 |
| 129 | MP0003787_abnormal_imprinting | 0.50820380 |
| 130 | MP0002102_abnormal_ear_morphology | 0.49624053 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.48212806 |
| 132 | MP0008872_abnormal_physiological_respon | 0.43785354 |
| 133 | MP0000609_abnormal_liver_physiology | 0.43497206 |
| 134 | MP0005384_cellular_phenotype | 0.43457751 |
| 135 | MP0002083_premature_death | 0.39623773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.01555097 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 4.97035093 |
| 3 | Colitis (HP:0002583) | 4.74618658 |
| 4 | Chronic otitis media (HP:0000389) | 4.66126213 |
| 5 | T lymphocytopenia (HP:0005403) | 4.43919937 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.31465332 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.27434732 |
| 8 | Myositis (HP:0100614) | 4.10217846 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.08262246 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.87133211 |
| 11 | Aplastic anemia (HP:0001915) | 3.85539212 |
| 12 | Abnormality of T cells (HP:0002843) | 3.81256147 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.79122701 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.72015386 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69051693 |
| 16 | Recurrent viral infections (HP:0004429) | 3.63175874 |
| 17 | IgG deficiency (HP:0004315) | 3.54404524 |
| 18 | Petechiae (HP:0000967) | 3.49542891 |
| 19 | Viral hepatitis (HP:0006562) | 3.46165995 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.27797746 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.27797746 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.21894626 |
| 23 | B lymphocytopenia (HP:0010976) | 3.20352778 |
| 24 | Abnormality of B cell number (HP:0010975) | 3.20352778 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.19768188 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 3.17862618 |
| 27 | Thrombocytosis (HP:0001894) | 3.17521631 |
| 28 | Lymphopenia (HP:0001888) | 3.13486550 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.10230167 |
| 30 | Basal cell carcinoma (HP:0002671) | 3.06729341 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.05784615 |
| 32 | Optic neuritis (HP:0100653) | 3.05784615 |
| 33 | Emphysema (HP:0002097) | 2.98803812 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98500622 |
| 35 | Chronic diarrhea (HP:0002028) | 2.97968532 |
| 36 | Orchitis (HP:0100796) | 2.95971749 |
| 37 | Nasal polyposis (HP:0100582) | 2.95947935 |
| 38 | Lip pit (HP:0100267) | 2.94743097 |
| 39 | Granulocytopenia (HP:0001913) | 2.90292481 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 2.81998788 |
| 41 | Eosinophilia (HP:0001880) | 2.81632393 |
| 42 | Abnormality of eosinophils (HP:0001879) | 2.81107196 |
| 43 | Thoracolumbar scoliosis (HP:0002944) | 2.80404702 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.80153616 |
| 45 | Verrucae (HP:0200043) | 2.79513567 |
| 46 | Papilloma (HP:0012740) | 2.79513567 |
| 47 | Cellulitis (HP:0100658) | 2.76545350 |
| 48 | Restrictive lung disease (HP:0002091) | 2.76154452 |
| 49 | Meningitis (HP:0001287) | 2.70062573 |
| 50 | Recurrent lower respiratory tract infections (HP:0002783) | 2.69768266 |
| 51 | Reticulocytopenia (HP:0001896) | 2.69314973 |
| 52 | Bronchitis (HP:0012387) | 2.64989450 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.63762414 |
| 54 | Vasculitis (HP:0002633) | 2.59739266 |
| 55 | Encephalitis (HP:0002383) | 2.59413939 |
| 56 | Overlapping toe (HP:0001845) | 2.57942059 |
| 57 | Acute myeloid leukemia (HP:0004808) | 2.52294812 |
| 58 | Hypoplasia of the thymus (HP:0000778) | 2.51635504 |
| 59 | Increased IgE level (HP:0003212) | 2.51326474 |
| 60 | IgA deficiency (HP:0002720) | 2.49512221 |
| 61 | Lymphoma (HP:0002665) | 2.47954180 |
| 62 | Leukocytosis (HP:0001974) | 2.47790821 |
| 63 | Chin dimple (HP:0010751) | 2.45694822 |
| 64 | Recurrent abscess formation (HP:0002722) | 2.45001977 |
| 65 | Hepatitis (HP:0012115) | 2.44800217 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.39431156 |
| 67 | 11 pairs of ribs (HP:0000878) | 2.37268167 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.35633211 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.34110203 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.34003153 |
| 71 | Combined immunodeficiency (HP:0005387) | 2.29972737 |
| 72 | Epistaxis (HP:0000421) | 2.28392428 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.27064556 |
| 74 | Papilledema (HP:0001085) | 2.23687680 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.23468394 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.23396592 |
| 77 | Hemoptysis (HP:0002105) | 2.22936821 |
| 78 | Prominent nose (HP:0000448) | 2.22123819 |
| 79 | Muscle fiber atrophy (HP:0100295) | 2.20701860 |
| 80 | Pustule (HP:0200039) | 2.20485802 |
| 81 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.19130822 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.18273313 |
| 83 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.17440470 |
| 84 | Leukopenia (HP:0001882) | 2.17337436 |
| 85 | Recurrent otitis media (HP:0000403) | 2.17275446 |
| 86 | Recurrent skin infections (HP:0001581) | 2.17164209 |
| 87 | Menstrual irregularities (HP:0000858) | 2.16803986 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.16721656 |
| 89 | Osteomyelitis (HP:0002754) | 2.15147900 |
| 90 | Abnormality of the columella (HP:0009929) | 2.14348620 |
| 91 | Acute hepatic failure (HP:0006554) | 2.13527701 |
| 92 | Myelodysplasia (HP:0002863) | 2.13462289 |
| 93 | Squamous cell carcinoma (HP:0002860) | 2.13448178 |
| 94 | Fatigue (HP:0012378) | 2.13275345 |
| 95 | Broad face (HP:0000283) | 2.12666195 |
| 96 | Pallor (HP:0000980) | 2.12484544 |
| 97 | Sparse scalp hair (HP:0002209) | 2.11552621 |
| 98 | Villous atrophy (HP:0011473) | 2.09946858 |
| 99 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09946858 |
| 100 | Erythema (HP:0010783) | 2.07010067 |
| 101 | Chronic sinusitis (HP:0011109) | 2.05394585 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.04978574 |
| 103 | Weak cry (HP:0001612) | 2.03638707 |
| 104 | Thyroiditis (HP:0100646) | 2.01263173 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.00643327 |
| 106 | Amaurosis fugax (HP:0100576) | 1.99995360 |
| 107 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99921818 |
| 108 | Obstructive lung disease (HP:0006536) | 1.99921818 |
| 109 | Keratoconjunctivitis (HP:0001096) | 1.99727913 |
| 110 | Hypothermia (HP:0002045) | 1.99090130 |
| 111 | Volvulus (HP:0002580) | 1.99076315 |
| 112 | Bronchiectasis (HP:0002110) | 1.97026238 |
| 113 | Acute lymphatic leukemia (HP:0006721) | 1.95522332 |
| 114 | Gastrointestinal stroma tumor (HP:0100723) | 1.95331416 |
| 115 | Joint swelling (HP:0001386) | 1.94131510 |
| 116 | Neutropenia (HP:0001875) | 1.91622462 |
| 117 | Chronic hepatic failure (HP:0100626) | 1.89612578 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 1.89403274 |
| 119 | Stomatitis (HP:0010280) | 1.89322300 |
| 120 | Recurrent bacterial skin infections (HP:0005406) | 1.88220000 |
| 121 | Abnormal pancreas size (HP:0012094) | 1.87720851 |
| 122 | Cheilitis (HP:0100825) | 1.86805601 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 1.86482347 |
| 124 | Abnormal hair whorl (HP:0010721) | 1.86283430 |
| 125 | Arterial thrombosis (HP:0004420) | 1.85826985 |
| 126 | Mediastinal lymphadenopathy (HP:0100721) | 1.85600921 |
| 127 | Xerostomia (HP:0000217) | 1.83962491 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.83904285 |
| 129 | Purpura (HP:0000979) | 1.83873009 |
| 130 | Increased IgM level (HP:0003496) | 1.83428729 |
| 131 | Ectropion (HP:0000656) | 1.83421540 |
| 132 | Carpal bone hypoplasia (HP:0001498) | 1.82575224 |
| 133 | Pancytopenia (HP:0001876) | 1.81407786 |
| 134 | Gangrene (HP:0100758) | 1.80176845 |
| 135 | Sepsis (HP:0100806) | 1.78956470 |
| 136 | Abnormality of the thymus (HP:0000777) | 1.76811464 |
| 137 | Dysmetric saccades (HP:0000641) | 1.75098368 |
| 138 | Abnormality of the peritoneum (HP:0002585) | 1.74363028 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.73931763 |
| 140 | Submucous cleft hard palate (HP:0000176) | 1.73210035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.72501110 |
| 2 | MAP4K1 | 4.17722989 |
| 3 | PRPF4B | 3.76055228 |
| 4 | RIPK4 | 3.51603812 |
| 5 | EIF2AK3 | 2.86608769 |
| 6 | KIT | 2.65778438 |
| 7 | TEC | 2.55501029 |
| 8 | IKBKE | 2.54828177 |
| 9 | JAK3 | 2.51817177 |
| 10 | ZAP70 | 2.34864468 |
| 11 | MAP3K10 | 2.32211357 |
| 12 | IRAK4 | 2.18887208 |
| 13 | TNIK | 2.18546440 |
| 14 | NLK | 2.12176168 |
| 15 | CDK12 | 2.11167008 |
| 16 | ITK | 2.05647613 |
| 17 | BTK | 2.03300532 |
| 18 | FGFR4 | 1.93278115 |
| 19 | SMG1 | 1.91929325 |
| 20 | TYK2 | 1.91499257 |
| 21 | MAP3K14 | 1.88852059 |
| 22 | STK10 | 1.79954337 |
| 23 | TAOK3 | 1.79065317 |
| 24 | NME2 | 1.78983011 |
| 25 | MST4 | 1.76726525 |
| 26 | LCK | 1.72224707 |
| 27 | PIM2 | 1.66873376 |
| 28 | BMPR2 | 1.62768870 |
| 29 | FGFR3 | 1.56706997 |
| 30 | FRK | 1.53504712 |
| 31 | NEK9 | 1.39412518 |
| 32 | CLK1 | 1.38230452 |
| 33 | MELK | 1.36592761 |
| 34 | JAK1 | 1.35491040 |
| 35 | SYK | 1.35038690 |
| 36 | TNK2 | 1.33148024 |
| 37 | TBK1 | 1.31368203 |
| 38 | TGFBR1 | 1.28821569 |
| 39 | TAF1 | 1.25376939 |
| 40 | IKBKB | 1.22484034 |
| 41 | VRK1 | 1.16977345 |
| 42 | PIM1 | 1.13313142 |
| 43 | EPHA3 | 1.12043899 |
| 44 | BMPR1B | 1.10666920 |
| 45 | STK24 | 1.05700606 |
| 46 | HCK | 1.05037918 |
| 47 | IRAK1 | 1.03627555 |
| 48 | FLT3 | 1.02082083 |
| 49 | SIK3 | 1.00827436 |
| 50 | MAP3K12 | 0.98602481 |
| 51 | STK16 | 0.98233917 |
| 52 | HIPK2 | 0.97728879 |
| 53 | PRKCH | 0.97318510 |
| 54 | MAPK7 | 0.96688327 |
| 55 | RPS6KB2 | 0.96541725 |
| 56 | LYN | 0.90166422 |
| 57 | TRPM7 | 0.89144365 |
| 58 | IRAK3 | 0.87986438 |
| 59 | SGK2 | 0.87350128 |
| 60 | CSF1R | 0.86843820 |
| 61 | SRPK1 | 0.85751982 |
| 62 | NEK6 | 0.84231395 |
| 63 | MAPKAPK5 | 0.83173983 |
| 64 | MAPK15 | 0.80819361 |
| 65 | MKNK1 | 0.80817556 |
| 66 | STK4 | 0.80363798 |
| 67 | EEF2K | 0.80308430 |
| 68 | PRKCQ | 0.78606218 |
| 69 | WNK1 | 0.77913729 |
| 70 | KDR | 0.77576042 |
| 71 | PIK3CG | 0.77479579 |
| 72 | YES1 | 0.77152161 |
| 73 | CDC7 | 0.74466687 |
| 74 | CDK6 | 0.73729578 |
| 75 | ZAK | 0.72916257 |
| 76 | CHUK | 0.71595141 |
| 77 | FES | 0.71201327 |
| 78 | RPS6KA5 | 0.71172254 |
| 79 | TGFBR2 | 0.70612066 |
| 80 | TLK1 | 0.69359549 |
| 81 | BRD4 | 0.68115348 |
| 82 | CDC42BPA | 0.67510890 |
| 83 | PASK | 0.67453260 |
| 84 | CDK8 | 0.67309937 |
| 85 | NME1 | 0.65447302 |
| 86 | CAMKK1 | 0.65028720 |
| 87 | BLK | 0.64215718 |
| 88 | JAK2 | 0.63649769 |
| 89 | DYRK3 | 0.63394810 |
| 90 | CAMKK2 | 0.63346377 |
| 91 | MUSK | 0.63230341 |
| 92 | GRK6 | 0.62707899 |
| 93 | LRRK2 | 0.61506028 |
| 94 | MAPK12 | 0.60295339 |
| 95 | MKNK2 | 0.60207323 |
| 96 | CSK | 0.59961208 |
| 97 | RPS6KA4 | 0.58460685 |
| 98 | MAP2K3 | 0.56300937 |
| 99 | CDK7 | 0.56100752 |
| 100 | STK38L | 0.55248191 |
| 101 | RPS6KA6 | 0.53570876 |
| 102 | ATR | 0.52795823 |
| 103 | MAP3K13 | 0.52427749 |
| 104 | SGK3 | 0.51704908 |
| 105 | PDK1 | 0.51498911 |
| 106 | CDK4 | 0.49297946 |
| 107 | SIK2 | 0.49076033 |
| 108 | MAPK4 | 0.48592737 |
| 109 | NUAK1 | 0.48542511 |
| 110 | MAP3K7 | 0.47484045 |
| 111 | MAPKAPK3 | 0.47409323 |
| 112 | EIF2AK2 | 0.45365509 |
| 113 | CDK9 | 0.44394054 |
| 114 | IRAK2 | 0.42896332 |
| 115 | CCNB1 | 0.42777309 |
| 116 | PIK3CA | 0.42593330 |
| 117 | MAPK11 | 0.40552253 |
| 118 | MARK3 | 0.39190590 |
| 119 | MAP3K5 | 0.38720738 |
| 120 | CHEK1 | 0.38112215 |
| 121 | MAPK13 | 0.36852176 |
| 122 | MAPKAPK2 | 0.36325423 |
| 123 | CDK3 | 0.36156755 |
| 124 | RPS6KL1 | 0.36054711 |
| 125 | RPS6KC1 | 0.36054711 |
| 126 | EPHB1 | 0.35892944 |
| 127 | MATK | 0.35123544 |
| 128 | ADRBK2 | 0.34587185 |
| 129 | MAPK3 | 0.34218889 |
| 130 | ATM | 0.31502989 |
| 131 | PKN2 | 0.29724034 |
| 132 | BCR | 0.28279775 |
| 133 | STK3 | 0.27461312 |
| 134 | SGK1 | 0.27258839 |
| 135 | FGR | 0.25547312 |
| 136 | CDK19 | 0.25362909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.25063303 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.14369278 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.11751047 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.50748661 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47212260 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.36924578 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36618112 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.32810831 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16916001 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.03479156 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92987051 |
| 12 | Protein export_Homo sapiens_hsa03060 | 1.81027865 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78223486 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.76751894 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.69157297 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68593705 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67376203 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67367454 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.65087810 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.55379427 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.55077448 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44627075 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42360036 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35909609 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.34819540 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27403689 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.26790796 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25587760 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25207398 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23101921 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.22632564 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20852816 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18966841 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15862285 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15504496 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.15098742 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.11326058 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.10196876 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09820352 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09146097 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.06752801 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.06175657 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 1.05591582 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05577748 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.05333412 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04821597 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04536069 |
| 48 | Alcoholism_Homo sapiens_hsa05034 | 1.03434200 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02501452 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98373826 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98164696 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97091604 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91698496 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90781297 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88331794 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87782345 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87513581 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86599795 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85993597 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.84846502 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84200879 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.83662388 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83522703 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81949663 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.81440443 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.81284169 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80180652 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79878260 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79539481 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75698954 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.71092986 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70177617 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.69687747 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66483740 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64638369 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62497571 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60215210 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58828692 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57443932 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.57333096 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56229766 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54895112 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54474903 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54235972 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.52342659 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51664023 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51581058 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.51182984 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50512387 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48413632 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47404696 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46804125 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46497470 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45277642 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45139884 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44214676 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.43602557 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43377447 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42649939 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.42550108 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.42549055 |
| 102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42518163 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41827458 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.40649514 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38404544 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38003907 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37422040 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37145976 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36455720 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36195918 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.34866862 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32856746 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31435801 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30250312 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30080845 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30023010 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29864850 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28962136 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.28910606 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28126154 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28104560 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27266428 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24503855 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.21680517 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18964302 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.18207542 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.17258806 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17130426 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15119523 |

